- Our Story
- In Memory
Researchers Reprogramming Skin Cells into Brain Cells to Understand Alzheimer's Disease
Collaboration with the New York Stem Cell Foundation will involve using skin samples and brain imaging to identify causes and cures
Sam Gandy, MD, PhD, of the Icahn School of Medicine at Mount Sinai is leading an international team of researchers working to reprogram skin cells into brain cells to gain a better understanding of Alzheimer's disease (AD). As part of the Consortium, Dr. Gandy is collaborating with Scott Noggle, PhD, the NYSCF - Charles Evans Senior Research Fellow for Alzheimer's Disease and Director of the New York Stem Cell Foundation (NYSCF)'s laboratory in Manhattan.
Dr. Gandy heads the Stem Cell Research Consortium funded by the Cure Alzheimer's Fund (CAF). The Consortium consists of six institutions that plan to directly investigate, for the first time, brain cells in petri dishes from individual patients who have the common form of AD.
To read the full article from Medical Science News, click here.